
Adamas Pharmaceuticals (ADMS)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Adamas Pharmaceuticals (ADMS) Stock
Start investing in Adamas Pharmaceuticals (ADMS)
About Adamas Pharmaceuticals (ADMS)
Market cap | $376.37M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 1.21M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -4.85x |
Today's range | — |
Debt / equity | — |
52 week range | $4.02 - $9.15 |
5 year debt / equity | -2995.86x |
Beta (LTM) | 0.04x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 10, 2021 |
Dividend payable date | — |
Adamas Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy ADMS stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in ADMS stock
Navigate to the Explore page. Then, type ADMS into the search bar. When you see ADMS stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased ADMS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Adamas Pharmaceuticals Stock Earnings
The value each ADMS share was expected to gain vs. the value that each ADMS share actually gained.
Adamas Pharmaceuticals (ADMS) reported Q2 2021 earnings per share (EPS) of -$0.27, beating estimates of -$0.29 by 6.90%. In the same quarter last year, Adamas Pharmaceuticals's earnings per share (EPS) was -$0.37. Adamas Pharmaceuticals is expected to release next earnings on 11/10/2021, with an earnings per share (EPS) estimate of $0.